Alhassan Sa-Eed, Eric S Donkor, Reuben E Arhin, Patience B Tetteh-Quarcoo, Simon K Attah, Daniel E K Kabotso, Fleischer C N Kotey, Nicholas T K D Dayie
{"title":"粗蜂胶提取物和组分的体外抗菌活性。","authors":"Alhassan Sa-Eed, Eric S Donkor, Reuben E Arhin, Patience B Tetteh-Quarcoo, Simon K Attah, Daniel E K Kabotso, Fleischer C N Kotey, Nicholas T K D Dayie","doi":"10.1093/femsmc/xtad010","DOIUrl":null,"url":null,"abstract":"<p><p>The search for antimicrobials in propolis presents a new dimension for addressing the problem of antimicrobial drug resistance. The aim of this study was to determine the antimicrobial activity of extracts of crude propolis collected from different regions in Ghana and their active fractions. The antimicrobial activity of the extracts, as well as that of the chloroform, ethyl acetate, and petroleum ether fractions of the active samples were determined using the agar well diffusion method. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the most active fractions were determined. The various crude propolis extracts frequently produced zones of inhibition against <i>Staphylococcus aureus</i> (17/20) than <i>Pseudomonas aeruginosa</i> (16/20), and <i>Escherichia coli</i> (1/20) test isolates. Chloroform and ethyl acetate solvents produced fractions possessing greater antimicrobial activity than the petroleum ether fraction. The mean MIC range of the most active fractions was greatest for <i>S. aureus</i> (76.0 ± 34.8-48.0 ± 33.0 mg/ml) than for <i>P. aeruginosa</i> (40.8 ± 33.3-30.4 ± 6.7 mg/ml) and <i>E. coli</i>, as was the mean MBC. Propolis has antimicrobial potential, and hence should be exploited as an alternative for the treatment of bacterial infections.</p>","PeriodicalId":73024,"journal":{"name":"FEMS microbes","volume":"4 ","pages":"xtad010"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165684/pdf/","citationCount":"2","resultStr":"{\"title\":\"<i>In vitro</i> antimicrobial activity of crude propolis extracts and fractions.\",\"authors\":\"Alhassan Sa-Eed, Eric S Donkor, Reuben E Arhin, Patience B Tetteh-Quarcoo, Simon K Attah, Daniel E K Kabotso, Fleischer C N Kotey, Nicholas T K D Dayie\",\"doi\":\"10.1093/femsmc/xtad010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The search for antimicrobials in propolis presents a new dimension for addressing the problem of antimicrobial drug resistance. The aim of this study was to determine the antimicrobial activity of extracts of crude propolis collected from different regions in Ghana and their active fractions. The antimicrobial activity of the extracts, as well as that of the chloroform, ethyl acetate, and petroleum ether fractions of the active samples were determined using the agar well diffusion method. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the most active fractions were determined. The various crude propolis extracts frequently produced zones of inhibition against <i>Staphylococcus aureus</i> (17/20) than <i>Pseudomonas aeruginosa</i> (16/20), and <i>Escherichia coli</i> (1/20) test isolates. Chloroform and ethyl acetate solvents produced fractions possessing greater antimicrobial activity than the petroleum ether fraction. The mean MIC range of the most active fractions was greatest for <i>S. aureus</i> (76.0 ± 34.8-48.0 ± 33.0 mg/ml) than for <i>P. aeruginosa</i> (40.8 ± 33.3-30.4 ± 6.7 mg/ml) and <i>E. coli</i>, as was the mean MBC. Propolis has antimicrobial potential, and hence should be exploited as an alternative for the treatment of bacterial infections.</p>\",\"PeriodicalId\":73024,\"journal\":{\"name\":\"FEMS microbes\",\"volume\":\"4 \",\"pages\":\"xtad010\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165684/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FEMS microbes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/femsmc/xtad010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEMS microbes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/femsmc/xtad010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
In vitro antimicrobial activity of crude propolis extracts and fractions.
The search for antimicrobials in propolis presents a new dimension for addressing the problem of antimicrobial drug resistance. The aim of this study was to determine the antimicrobial activity of extracts of crude propolis collected from different regions in Ghana and their active fractions. The antimicrobial activity of the extracts, as well as that of the chloroform, ethyl acetate, and petroleum ether fractions of the active samples were determined using the agar well diffusion method. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the most active fractions were determined. The various crude propolis extracts frequently produced zones of inhibition against Staphylococcus aureus (17/20) than Pseudomonas aeruginosa (16/20), and Escherichia coli (1/20) test isolates. Chloroform and ethyl acetate solvents produced fractions possessing greater antimicrobial activity than the petroleum ether fraction. The mean MIC range of the most active fractions was greatest for S. aureus (76.0 ± 34.8-48.0 ± 33.0 mg/ml) than for P. aeruginosa (40.8 ± 33.3-30.4 ± 6.7 mg/ml) and E. coli, as was the mean MBC. Propolis has antimicrobial potential, and hence should be exploited as an alternative for the treatment of bacterial infections.